Analyst Ranking
Bottom 4%
#4787 out of 4935 analysts
Average Return
-10.19%
Win Rate
36%29 out of 81
Risk vs Reward
Poor
Good

Leonid Timashev's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Newamsterdam Pharma Co NvNAMS
+164.57%$7.17$18.97
2023-10-30 -
2024-10-29
Buy
Edgewise Therapeutics IncEWTX
+131.48%$7.56$17.50
2023-06-28 -
2024-06-27
Buy
Axsome Therapeutics IncAXSM
+57.23%$82.11$129.10
2024-02-21 -
2025-02-20
Buy
Axsome Therapeutics IncAXSM
+56.88%$76.72$120.36
2024-03-26 -
2025-03-25
Buy
Pyxis Oncology IncPYXS
+56.70%$2.24$3.51
2023-09-05 -
2024-09-04
Buy

Leonid Timashev Analyst Color

Get additional color on Leonid Timashev's coverage of popular stocks

Leonid Timashev's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Ideaya Biosciences IncIDYA
1Buy$30.00+31.58%Maintains
2 days ago
Beone Medicines LtdONC
1Buy$311.00+22.74%Reiterates
14 days ago
Verastem IncVSTM
1Buy$12.00+153.16%Maintains
16 days ago
Cormedix IncCRMD
1Buy$17.00+45.18%Reiterates
21 days ago
Adc Therapeutics SaADCT
1Buy$5.00+51.52%Maintains
21 days ago
Nuvation Bio IncNUVB
1Buy$6.00+159.74%Maintains
24 days ago
Axsome Therapeutics IncAXSM
12Buy$186.00+67.98%Maintains
a month ago
Insmed IncINSM
3Buy$106.00+9.66%Maintains
a month ago
Edgewise Therapeutics IncEWTX
13Buy$48.00+246.07%Reiterates
a month ago
Perspective Therapeutics IncCATX
1Buy$16.00+289.29%Maintains
a month ago
Biohaven LtdBHVN
12Hold$21.00+39.72%Downgrades
2 months ago
Cytokinetics IncCYTK
3Buy$80.00+118.64%Maintains
2 months ago
Alkermes PLCALKS
2Hold$40.00+31.32%Maintains
2 months ago
Pyxis Oncology IncPYXS
6Buy$8.00+572.27%Reiterates
4 months ago
Brc IncBRCC
1Strong Buy$3.00+88.68%Maintains
4 months ago
Newamsterdam Pharma Co NvNAMS
6Buy$40.00+81.65%Reiterates
6 months ago
Incyte CorpINCY
1Hold$70.00-0.48%Reiterates
6 months ago
Compass Pathways PLCCMPS
4Buy$18.00+383.87%Reiterates
6 months ago
Legend Biotech CorpLEGN
11Buy$86.00+116.57%Reiterates
7 months ago
Design Therapeutics IncDSGN
8Hold$4.00-0.99%Reiterates
a year ago
Neubase Therapeutics IncNBSE
1Hold$20.00N/ADowngrades
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.